1.      Finer N.N, Barrington K.J. Nitric oxide for respiratory failure in infants born at or near term Cochrane Database Syst Rev. 2006; CD000399

2.      Fraisse A, Geva T, Gaudart J, et al. Doppler echocardiographic predictors of outcome in newborns with persistent pulmonary hypertension. Cardiol Young. 2004;14:277–283.

3.      Gao Y, Raj JU. Regulation of the pulmonary circulation in the fetus and newborn. Physiol Rev 2010;90:1291e335.

4.      Gersony WM. Persistence of the fetal circulation: a commentary. J Pediatr 1972; 82(6):1103–1106.

5.      Giesinger RE, McNamara PJ. Hemodynamic instability in the critically ill neonate: An approach to cardiovascular support based on disease pathophysiology. Semin Perinatol. 2016;40:174–188.

6.      Goldsmith J KE, Suresh G, Keszler M. Asiste Assisted Ventilation of the Neonate Philadelphia: Elsevier; 2017.

7.      Jain A, McNamara P.Persistent pulmonary hypertension of the newborn: Advances in diagnosis and treatment. Seminars in Fetal and Neonatal Medicine, Volume 20, Issue 4, 262 – 271

8.      James AT, Corcoran JD, McNamara PJ, et al. The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension. Cardiol Young. 2016;26:90–99.

9.      Kahveci H, Yilmaz O, Avsar UZ, et al. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn. Pediatr Pulmonol 2014; 49(12): 1205–1213

10.  Lakshminrusimha S. Persistent Pulmonary Hypertension of the Newborn. NeoReviews 2015; 16(12: e680.

11.  Lotze A, Mitchell BR, Bulas DI, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr. 1998;132:40–47

12.  Malowitz JR, Forsha DE, Smith PB, et al. Right ventricular echocardiographic indices predict poor outcomes in infants with persistent pulmonary hypertension of the newborn. Eur Heart J Cardiovasc Imaging. 2015;16:1224–1231.

13.  Martinho S, Adão R, Leite-Moreira AF, et al. Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches. Front Pediatr 2020; 8: 342. [PubMed: 32850518]

14.  Morrow LA, Wagner BD, Ingram DA, et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J respiratory Crit care Med. 2017;196:364–374

15.  Qasim A, Jain SK. Milrinone Use in Persistent Pulmonary Hypertension of the Newborn. Neoreviews. 2020;21(3):e165-e78

16.  Singh Y, Katheria AC and Vora F. Advances in Diagnosis and Management of Hemodynamic Instability in Neonatal Shock. Front Pediatr 2018; 6: 2. doi: 10.3389/fped.2018.00002. [PubMed: 29404312]

17.  Singh Y, Lakshminrusimha S. Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn. Clin Perinatol. 2021 Aug;48(3):595-618.

18.  Singh Y, Tissot C. Echocardiographic Evaluation of Transitional Circulation for the Neonatologists. Front Pediatr 2018; 6:140.

19.  Steinhorn RH AS. Persistent Pulmonary Hypertension. In: Gleason AC JS, editor. Avery’s Diseases of Newborn. 10 ed: Elsevier; 2018. p. 768-78.

20.  Tworetzky W, Bristow J, Moore P, et al. Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Lancet 2001; 357(9250): 118–120.